Pratik Multani
Chief Tech/Sci/R&D Officer bij ORIC PHARMACEUTICALS, INC.
Vermogen: 683 478 $ op 31-03-2024
Profiel
Pratik S.
Multani is currently an Independent Director at Chimerix, Inc. and Erasca, Inc. He is also a Principal at the American Board of Internal Medicine.
In addition, he serves as the Chief Medical Officer at Oric Pharmaceuticals, Inc. Dr. Multani previously held positions as a Senior Director-Medical Research & Development at Biogen, Inc. and as a Vice President-Clinical Development at Kalypsys, Inc. He also served as the Chief Medical Officer at Kanisa Pharmaceuticals, Inc. and Ignyta, Inc. Dr. Multani has an undergraduate degree from Yale University, a doctorate from Harvard Medical School, and a graduate degree from Harvard T.H.
Chan School of Public Health.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ERASCA, INC.
0.11% | 01-01-2024 | 172 866 ( 0.11% ) | 356 104 $ | 31-03-2024 |
ORIC PHARMACEUTICALS INC
0.04% | 02-01-2024 | 23 809 ( 0.04% ) | 327 374 $ | 31-03-2024 |
CHIMERIX, INC.
-.--% | 09-06-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Pratik Multani
| Bedrijven | Functie | Begin |
|---|---|---|
| ERASCA, INC. | Director/Board Member | 01-07-2018 |
| CHIMERIX, INC. | Director/Board Member | 24-02-2020 |
| ORIC PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01-09-2018 |
American Board of Internal Medicine
 American Board of Internal Medicine Miscellaneous Commercial ServicesCommercial Services The American Board of Internal Medicine operates as a self-appointed physician evaluation organization. The private company is based in Philadelphia, PA. The CEO of the company is Richard J. Baron. | Corporate Officer/Principal | - |
Eerdere bekende functies van Pratik Multani
| Bedrijven | Functie | Einde |
|---|---|---|
| IGNYTA INC | Chief Tech/Sci/R&D Officer | 01-01-2017 |
| FATE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-01-2015 |
Kalypsys, Inc.
 Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Kalypsys, Inc. discovered and developed novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases. The firm advanced its proprietary lead program, a novel, non-corticosteroid small molecule formulated for intranasal delivery, into clinical proof of concept studies. The company was founded by Pratik Shah, Jeremy S. Caldwell, Randall W. King, Kevin D. Lustig, Peter G. Schultz and Robert Downs in 2001 and was headquartered in Solana Beach, CA. | Chief Tech/Sci/R&D Officer | 01-03-2009 |
Kanisa Pharmaceuticals, Inc.
 Kanisa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kanisa Pharmaceuticals, Inc. develops pharmaceuticals and provides medical services. The company develops drugs for diagnosis and treatment of cancer. It was founded by David A. Socks and is located in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01-01-2009 |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Corporate Officer/Principal | - |
Opleiding van Pratik Multani
| Yale University | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
| Harvard T.H. Chan School of Public Health | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| BIOGEN INC. | Health Technology |
| CHIMERIX, INC. | Health Technology |
| FATE THERAPEUTICS, INC. | Health Technology |
| ORIC PHARMACEUTICALS, INC. | Health Technology |
| ERASCA, INC. | Health Technology |
| Bedrijven in privébezit | 7 |
|---|---|
Kalypsys, Inc.
Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Kalypsys, Inc. discovered and developed novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases. The firm advanced its proprietary lead program, a novel, non-corticosteroid small molecule formulated for intranasal delivery, into clinical proof of concept studies. The company was founded by Pratik Shah, Jeremy S. Caldwell, Randall W. King, Kevin D. Lustig, Peter G. Schultz and Robert Downs in 2001 and was headquartered in Solana Beach, CA. | Health Technology |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Health Technology |
Kanisa Pharmaceuticals, Inc.
Kanisa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kanisa Pharmaceuticals, Inc. develops pharmaceuticals and provides medical services. The company develops drugs for diagnosis and treatment of cancer. It was founded by David A. Socks and is located in San Diego, CA. | Health Technology |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
American Board of Internal Medicine
American Board of Internal Medicine Miscellaneous Commercial ServicesCommercial Services The American Board of Internal Medicine operates as a self-appointed physician evaluation organization. The private company is based in Philadelphia, PA. The CEO of the company is Richard J. Baron. | Commercial Services |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Ignyta, Inc. operates as a medicine biotechnology company. The firm engages in the discovering, acquiring, developing and commercializing targeted new drugs for cancer patients. The company was founded by Jonathan E. Lim on September 13, 2011 and is headquartered in South San Francisco, CA. | Health Technology |
